Biotech Values

[DewDiligence]

>Pharming still hasn't offered to buy the company? Hmmm...<

I think Pharming would likely have offered to buy GTC for about $2/sh if the EMEA appeal had failed. Whether GTC would have accepted the offer is hard to say.

Now, it’s a different story. GTC has absolutely no need to entertain an offer from anybody unless it’s an offer that’s simply too good to refuse. More than likely, they will remain independent. Regards, Dew